Diagnostics and Tools February 2024

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• Freenome, Inc. closed a $254MM Series A Financing, led by Roche Diagnostics Corporation
• Triple Ring Technologies received funding from 1315 Capital
• Renovaro Biosciences Inc. announced its acquisition of Cyclomics